Cargando…

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies

α-Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, are a class of neurodegenerative diseases exhibiting intracellular inclusions of misfolded α-synuclein (αSyn), referred to as Lewy bodies or oligodendroglial cytoplasmic inclusions (Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Matthias, Candelise, Niccolò, Canaslan, Sezgi, Altmeppen, Hermann C., Matschke, Jakob, Glatzel, Markus, Younas, Neelam, Zafar, Saima, Hermann, Peter, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012698/
https://www.ncbi.nlm.nih.gov/pubmed/36915212
http://dx.doi.org/10.1186/s40035-023-00342-4
_version_ 1784906657690550272
author Schmitz, Matthias
Candelise, Niccolò
Canaslan, Sezgi
Altmeppen, Hermann C.
Matschke, Jakob
Glatzel, Markus
Younas, Neelam
Zafar, Saima
Hermann, Peter
Zerr, Inga
author_facet Schmitz, Matthias
Candelise, Niccolò
Canaslan, Sezgi
Altmeppen, Hermann C.
Matschke, Jakob
Glatzel, Markus
Younas, Neelam
Zafar, Saima
Hermann, Peter
Zerr, Inga
author_sort Schmitz, Matthias
collection PubMed
description α-Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, are a class of neurodegenerative diseases exhibiting intracellular inclusions of misfolded α-synuclein (αSyn), referred to as Lewy bodies or oligodendroglial cytoplasmic inclusions (Papp–Lantos bodies). Even though the specific cellular distribution of aggregated αSyn differs in PD and DLB patients, both groups show a significant pathological overlap, raising the discussion of whether PD and DLB are the same or different diseases. Besides clinical investigation, we will focus in addition on methodologies, such as protein seeding assays (real-time quaking-induced conversion), to discriminate between different types of α-synucleinopathies. This approach relies on the seeding conversion properties of misfolded αSyn, supporting the hypothesis that different conformers of misfolded αSyn may occur in different types of α-synucleinopathies. Understanding the pathological processes influencing the disease progression and phenotype, provoked by different αSyn conformers, will be important for a personalized medical treatment in future.
format Online
Article
Text
id pubmed-10012698
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100126982023-03-15 α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies Schmitz, Matthias Candelise, Niccolò Canaslan, Sezgi Altmeppen, Hermann C. Matschke, Jakob Glatzel, Markus Younas, Neelam Zafar, Saima Hermann, Peter Zerr, Inga Transl Neurodegener Review α-Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, are a class of neurodegenerative diseases exhibiting intracellular inclusions of misfolded α-synuclein (αSyn), referred to as Lewy bodies or oligodendroglial cytoplasmic inclusions (Papp–Lantos bodies). Even though the specific cellular distribution of aggregated αSyn differs in PD and DLB patients, both groups show a significant pathological overlap, raising the discussion of whether PD and DLB are the same or different diseases. Besides clinical investigation, we will focus in addition on methodologies, such as protein seeding assays (real-time quaking-induced conversion), to discriminate between different types of α-synucleinopathies. This approach relies on the seeding conversion properties of misfolded αSyn, supporting the hypothesis that different conformers of misfolded αSyn may occur in different types of α-synucleinopathies. Understanding the pathological processes influencing the disease progression and phenotype, provoked by different αSyn conformers, will be important for a personalized medical treatment in future. BioMed Central 2023-03-14 /pmc/articles/PMC10012698/ /pubmed/36915212 http://dx.doi.org/10.1186/s40035-023-00342-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Schmitz, Matthias
Candelise, Niccolò
Canaslan, Sezgi
Altmeppen, Hermann C.
Matschke, Jakob
Glatzel, Markus
Younas, Neelam
Zafar, Saima
Hermann, Peter
Zerr, Inga
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title_full α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title_fullStr α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title_full_unstemmed α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title_short α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
title_sort α-synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012698/
https://www.ncbi.nlm.nih.gov/pubmed/36915212
http://dx.doi.org/10.1186/s40035-023-00342-4
work_keys_str_mv AT schmitzmatthias asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT candeliseniccolo asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT canaslansezgi asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT altmeppenhermannc asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT matschkejakob asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT glatzelmarkus asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT younasneelam asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT zafarsaima asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT hermannpeter asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies
AT zerringa asynucleinconformersreveallinktoclinicalheterogeneityofasynucleinopathies